Hemophilia of Georgia Names Edith A. Rosato Chief Executive Officer

Staff Report From Metro Atlanta CEO

Monday, February 18th, 2019

Hemophilia of Georgia (HoG), the premier organization in Georgia dedicated to providing services and support for people with inherited bleeding disorders, announces the appointment of Edith Rosato, R.Ph., IOM,as its Chief Executive Officer, effective March 11.

Rosato will lead HoG’s dedicated team of professionals while growing the value of the organization to those with inherited bleeding disorders, donors, sponsors, partners and other stakeholders. She will lead efforts to expand relationships with Hemophilia Treatment Centers, federal and state legislators, and the broader bleeding disorders network.

“Edith’s strategic vision and distinguished career in healthcare and nonprofit management make her the perfect choice to lead Hemophilia of Georgia into the future,” says Tom Singh, a Senior Vice President and Senior Resident Director with Merrill Lynch who is HoG’s Chief Governance Officer. “Her strong commitment to our mission and deep knowledge of pharmacy operations will serve our community well and advance our strategic objectives. We’re thrilled to welcome Edith aboard.”

Singh further notes that Rosato is a results-driven executive with strong advocacy and coalition-building skills. She previously served as the CEO of the Academy of Managed Care Pharmacy and Board Chair of its foundation, where she grew the budget to $12 million and the staff to 45. Prior to that, she served as President of the National Association of Chain Drug Stores Foundation and Senior VP, Pharmacy Affairs for the association.  She also held key positions with Wyeth-Ayerst Laboratories, and started her career with CVS, moving from registered pharmacist manager to a corporate role at the company’s headquarters.

“As a veteran of the healthcare association world, I’m excited to join Hemophilia of Georgia,” Rosato says, “and continue my commitment to expand access to quality healthcare services. In particular, I am eager to advocate for and work to ensure those with bleeding disorders have ready access to the support, resources and tools they need, enabling them to live as normally and productively as possible.”